The ethics of placebo

In a clinical trial, we usually think of risk in terms of the new active compound - will it have unwanted effects. However, two analyses in The BMJ are concerned about the risk associated with the control arm.

Robin Emsley is a professor of psychiatry at Stellenbosch University in South Africa, he and colleagues have written about the risk...